Abstract, Snapshot, Market Analysis & Market Definition: Global Nuclear Medicine Radioisotopes Market
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics. In 2019, the market size of Nuclear Medicine Radioisotopes is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nuclear Medicine Radioisotopes. This report studies the global market size of Nuclear Medicine Radioisotopes, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Nuclear Medicine Radioisotopes production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019
Market Segmentation: Global Nuclear Medicine Radioisotopes Market
Segmentation by Product Type : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Top Companies & Key Players: Global Nuclear Medicine Radioisotopes Market
The report offers a detailed analysis of several leading Nuclear Medicine Radioisotopes manufacturers including:
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Key Insights Covered: Global Nuclear Medicine Radioisotopes Market
1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Nuclear Medicine Radioisotopes industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Nuclear Medicine Radioisotopes industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Nuclear Medicine Radioisotopes industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Nuclear Medicine Radioisotopes industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Nuclear Medicine Radioisotopes industry.
Research Methodology: Global Nuclear Medicine Radioisotopes Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other